TCL Archive Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa. January 7, 2005
TCL Archive GAO Investigation Of Cancer Control Focuses On Five Contracts, Finds Alleged Deficiencies July 18, 1980